Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roger Bernard Titman is active.

Publication


Featured researches published by Roger Bernard Titman.


Bioorganic & Medicinal Chemistry | 2000

Structural studies on bioactive compounds. Part 29 ☆: Palladium catalysed arylations and alkynylations of sterically hindered immunomodulatory 2-amino-5-halo-4,6-(disubstituted)pyrimidines

Duncan R. Hannah; Edward C. Sherer; Roy V. Davies; Roger Bernard Titman; Charles A. Laughton; Malcolm F. G. Stevens

The immunological agent bropirimine 5 is a tetra-substituted pyrimidine with anticancer and interferon-inducing properties. Synthetic routes to novel 5-aryl analogues of bropirimine have been developed and their potential molecular recognition properties analysed by molecular modelling methods. Sterically challenged 2-amino-5-halo-6-phenylpyrimidin-4-ones (halo = Br or I) are poor substrates for palladium catalysed Suzuki cross-coupling reactions with benzeneboronic acid because the basic conditions of the reaction converts the amphoteric pyrimidinones to their unreactive enolic forms. Palladium-mediated reductive dehalogenation of the pyrimidinone substrates effectively competes with cross-coupling. 2-Amino-5-halo-4-methoxy-6-phenylpyrimidines can be converted to a range of 5-aryl derivatives with the 5-iodopyrimidines being the most efficient substrates. Hydrolysis of the 2-amino-5-aryl-4-methoxy-6-phenylpyrimidines affords the required pyrimidin-4-ones in high yields. Semi-empirical quantum mechanical calculations show how the nature of the 5-substituent influences the equilibrium between the 1H- and 3H-tautomeric forms, and the rotational freedom about the bond connecting the 6-phenyl group and the pyrimidine ring. Both of these factors may influence the biological properties of these compounds.


Journal of Chemical Research-s | 1997

Novel Preparation of 1-Aryl-3-(2-hydroxyphenyl)-2-pyrazolin-5-ones and their Conversion into 2-Aryl-4-methyl[1]benzopyrano[4,3-c]pyrazol-3(2H)-ones†

Jayne A. Froggett; Michael Henry Hockley; Roger Bernard Titman

1-Aryl-3-(2-hydroxyphenyl)-2-pyrazolin-5-ones are prepared from 4-hydroxycoumarin and arylhydrazines and then cyclised with triethyl orthoacetate to give 2-aryl-4-methyl[1]benzopyrano[4,3-c]pyrazol-3(2H)-ones.


Journal of The Chemical Society-perkin Transactions 1 | 1997

Use of highly stereospecific 1,3-dipolar cycloadditions of cyclic nitrones with acetylenes in the preparation of novel heterocyclic ring systems

W. Russell Bowman; Roy V. Davies; Alexandra M. Z. Slawin; Gian S. Sohal; Roger Bernard Titman; David J. Wilkins

Cyclic nitrones with substituents α to the nitrogen atom undergo 1,3-dipolar cycloadditions in a stereo- and regio-specific manner with acetylenes. The nitrone 3 reacts with methyl propiolate, methyl phenylpropiolate and methyl acetylpropiolate to give the corresponding pyrrolo[1,2-b]isoxazoles 5, 8 and 13 respectively. Compound 13 reacts with 4-chlorophenylhydrazine to afford the pyrazolo[4,3-a]pyrrolizine 15 by a novel rearrangement. The nitrone 18 undergoes a 1,3-dipolar cycloaddition with methyl propiolate in a stereo- and regio-specific manner to give the isoxazolo[2,3-a]pyridine 19. The nitrone 18, when reacted with methyl acetylpropiolate, gives a mixture of regioisomers in a ratio of 3∶2. The major regioisomer 21 reacts with 4-chlorophenylhydrazine to afford the novel pyrazolo[4,3-a]indolizine ring system 23. The bicyclic nitrone 26 reacts with methyl propiolate and methyl acetylpropiolate to give the cycloadducts 27 and 28 respectively; both these compounds contain the novel isoxazolo[3,2-i]indole ring system.


Archive | 1995

Azolyl-cyclic amine derivatives with immunomodulatory activity

David George Webber; Gerald Tometzki; Michael Henry Hockley; Roger Bernard Titman; Roy V. Davies; Paul Bradley


Archive | 1987

Antiulcer benzimidazole derivatives

Michael Henry Hockley; Roger Bernard Titman


Archive | 1989

Therapeutic [1]benzothiopyrano[4,3-c]pyrazoles.

John Gareth Bowen; Michael Henry Hockley; John Rosindale Housley; Ian Michael Hunneyball; Roger Bernard Titman; David George Webber


Archive | 1993

BENZOPYRANO(4,3-C)PYRAZOLES, THEIR PREPARATION AND THEIR USE AS IMMUNOMODULATORS

Roger Bernard Titman; Michael Henry Hockley


Journal of Labelled Compounds and Radiopharmaceuticals | 1997

Synthesis of a novel antiinflammatory agent, BTS 71321, singly labelled with carbon-14 in two positions

Maurice W. Baker; Michael V. Mewse; Stephen W. Shutler; Lucyna M. Taylor; Roger Bernard Titman


Journal of Chemical Research-s | 1995

SYNTHESIS OF NOVEL PYRAZOLOBENZISOXAZOLE RING SYSTEMS VIA A 1,3-DIPOLAR CYCLOADDITION REACTION

N. J. Howe; C. Lee; Roger Bernard Titman; David J. Wilkins


Archive | 1994

Azolyl cyclic amine derivatives with immunomodulating effect

David George Webber; Gerald Tometzki; Michael Henry Hockley; Roger Bernard Titman; Roy V. Davies; Paul Bradley

Collaboration


Dive into the Roger Bernard Titman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roy V. Davies

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Lee

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gian S. Sohal

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge